References
- ValgimigliMMinarelliMAntiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacyAm Heart J20101606 SupplS36S4121147290
- MenownIBContemporary management of coronary heart diseaseJR Coll Physicians Edinb20104014447
- EmeryRWKroghCCMcAdamsSLong-term follow up of patients undergoing reoperative surgery with aortic or mitral valve replacement using a St. Jude Medical prosthesisJ Heart Valve Dis201019447348420845896
- WuZJYangSFZhengSSConstruction and biological activities of human tPA eukaryotic expression plasmidHepatobiliary Pancreat Dis Int20043451151515567735
- PodrazikRMWhitehillTAEkhteraeDHigh-level expression of recombinant human tPA in cultivated canine endothelial cells under varying conditions of retroviral gene transferAnn Surg199221644464521417194
- EkhteraeDStanleyJCRetroviral vector-mediated transfer and expression of human tissue plasminigen activator gene in human endothelial and vascular smooth muscle cellsJ Vasc Surg19952169539627776475
- AlbersGWAmarencoPEastonJDAntithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest20041263 Suppl483S512S15383482
- JiSYJiJYangXHLingWPExperimental study on construction of recombinant tPa gene plasmid to prevent the thrombosis after mechanical valve replacementSouth China Journal of Cardiovascular Diseases2006122132135
- JiJZhangHWZhangZJLingWPTransfection of tissue-type plasminogen activator gene to prevent vascular anatomotic restenosis after coronary bypassChina Journal of Modern Medicine2007171416831686
- ArnedoAIracheJMMerodioMEspuelas MillánMSAlbumin nanoparticles improved the stability nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotideJ Control Release20049421722714684285
- AynieIVauthierCChacunHSpongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotidesAntisense Nucleic Acid Drug Dev1999930131210435755
- LangerKBalthasarSVogelVOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm200325716918012711172
- JiSYJiJYangXHLingWPStudy on construction of nano tPA plasmid to prevent thrombosis after mechanical valve replacement in dogsChina Journal of Modern Medicine2009191929192923
- WangZXWangZGTreatment of ultrasound contrast agents for gene or drug deliveryChin J Interv Imaging200634304308
- PorterTRXieFTherapeutic ultrasound for gene deliveryEchocardiography200118434935311415508
- ZhaoYZLuCRecent advances in the applications of ultrasonic microbubbles as gene delivery systemsActa Pharmaceutica Sinica200742212713117518038
- LaoYXiuJCProgress of ultrasound microbubble contrast agent with gene and drug targeting therapyJ Med Imaging2007171213951361
- ZhangYDGuoYLiuWDAlbumin nanoparticles used as gene carrierChin J Exp Surg2004211214561458
- DuYFWanMXZhaoWStudy on the preparation of a new sugar albumin microbubble ultrasound contrast agentActa Pharmaceutica Sinica20013611859862
- LingZYWangZRanHTExperiment study on ultrasound-mediated microbubble destruction deliver VEGF gene to ischemic myocardium of ratsChinese Ultrasound Med2002187502504
- ArnedoAEspuelasSIracheJMAlbumin nanoparticles as carriers for a phosphodiester oligonucleotideInt J Pharm2002244597212204565
- LiuXBCaiMYPreparation and immunological characterization of mitoxantrone-loaded immuno-nanoparticles against human hepatomChinese Journal of Immunology200016526222652622269
- WangKMaGHPreparation and characterization of albumin nanospheres as drug carrierChinese Journal of Process Engineering200442156159
- OuDBZhengQSEmbryonic stem cell differentiation towards cardiomyocytes and its application in cardiac tissue engineeringJournal of Clinical Rehabilitative Tissue Engineering Research2008123467196722